US20010018516A1 - Oxazoline or oxazine acetoacetate aqueous coating compositions - Google Patents

Oxazoline or oxazine acetoacetate aqueous coating compositions Download PDF

Info

Publication number
US20010018516A1
US20010018516A1 US09/819,242 US81924201A US2001018516A1 US 20010018516 A1 US20010018516 A1 US 20010018516A1 US 81924201 A US81924201 A US 81924201A US 2001018516 A1 US2001018516 A1 US 2001018516A1
Authority
US
United States
Prior art keywords
alkyl
aryl
hydrogen
compound
polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/819,242
Other versions
US6433116B2 (en
Inventor
Bill Culbertson
David Trumbo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/819,242 priority Critical patent/US6433116B2/en
Publication of US20010018516A1 publication Critical patent/US20010018516A1/en
Application granted granted Critical
Publication of US6433116B2 publication Critical patent/US6433116B2/en
Assigned to JOHNSON POLYMER, LLC reassignment JOHNSON POLYMER, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JOHNSONDIVERSEY, INC. F/K/A JOHNSON COMMERCIAL MARKETS, INC.
Assigned to BASF CORPORATION reassignment BASF CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: JOHNSON POLYMER, LLC.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/02—Polyamines
    • C08G73/0233—Polyamines derived from (poly)oxazolines, (poly)oxazines or having pendant acyl groups

Definitions

  • This invention relates to an aqueous coating composition such as coatings, inks, coverprint varnish and surface treatment applications containing an oxazoline or oxazine acetoacetate polymer.
  • Organic compounds or polymers with the acetoacetamide, acetoacetanilide, or acetoacetate type functionality are known to react with a variety of other functional chemicals (1-5), including such things as amines, aldehydes, and isocyanates, giving various adducts in excellent yields at low reaction temperatures (2).
  • the acetoacetamide, acetoacetanilide, or acetoacetate group, with amine catalysts will combine readily with the acrylate functionality, via what is commonly called the Michael addition reaction (2,5,6).
  • acetoacetanilide, acetoacetamide, or acetoacetate groups are known to readily react with various metal compounds, such as CaO, Ca(OH) 2 , BaO, CoCl 2 , NiCI 2 , etc. to form metal complexes (1,3), where the chemistry has been used to prepare polymeric catalysts (2,7,8) and crosslinked coatings (6,9-1 1).
  • metal compounds such as CaO, Ca(OH) 2 , BaO, CoCl 2 , NiCI 2 , etc.
  • cyclic imino ethers such as oxazolines and oxazines will undergo cationic, ring-opening polymerizations (12) and zwitterionic copolymerization with such things as acrylic acid, maleimides, anhydrides, lactones, etc. (13-17).
  • molecules with the oxazoline or oxazine residues will undergo ring-opening reactions with compounds such as carboxylic acids, thiols (HS-groups), phenols, alkyl halides, etc., giving 1-to-1 adducts (18-24), allowing for step-growth copolymerizations to be readily achieved with difunctional monomers.
  • oxazolines and oxazines are excellent intermediates for synthesis of variety of polymeric materials, both thermoplastics and thermosets, by chain-growth and step-growth polymerization mechanisms or combinations thereof.
  • synthesis and polymerization of oxazoline and oxazine methacrylate aqueous coating compositions are also known (27).
  • novel compound of this invention has the following formula:
  • R is an alkyl group containing 1-5 carbon atoms or an aryl, substituted aryl, substituted or unsubstituted heteroaryl, alkyl-aryl, alkylether-aryl or O;
  • R. and R 2 are hydrogen or a methyl group;
  • X is O, NH, NR′ wherein R′ is an alkyl group containing 1-5 carbon atoms, or O—R′′ or NR′′ wherein O—R′′ is O-alkyl-O or O-alkyl, NR′′ is O-alkyl-ONH, or
  • alkyl contains 1-5 carbon atoms and n is 0 or 1.
  • the compounds of this invention are monomers which may be polymerized or copolymerized, via cationic, ring-opening polymerization of the cyclic imino ether residues, producing polymers with pendant acetoacetamide, acetoacetanilide and/or acetoacetate groups.
  • Polymers of the aforesaid type may be readily crosslinked, via a variety of reactions as explained in the background art, to produce crosslinked materials useful in coatings, adhesives, and other applications. Further, these monomers and polymers are shown to readily form metal complexes with a variety of metal salts, giving in many cases, highly colored monomer-metal or macromolecular-metal complexes.
  • the compound where R is aryl, X is NH, R, R 1 and R 2 are CH 3 and n is 0 is prepared by reacting ethylaminobenzoate with methylaminopropanol to yield a dimethyl derivative of aminophenyl oxazoline with the resulting oxazaline treated with TDO.
  • the compound where R is alkyl, X is alkyl, R 1 and R 2 are hydrogen and n is 0 is prepared by reacting an alkylamino alkylnitrile with ethanolamine to obtain alkylamino alkyloxazoline which is subsequently treated with TDO.
  • R, R 1 , R 2 and n are as immediately and previously described but X is O-alkyl, it is obtained by reacting hydroxyalkyl oxazoline and TDO.
  • R 1 and R 2 are hydrogen, n is 0 and X is O-alkyl-O, O-alkyl-CNH or
  • aminophenyl oxazoline was treated with an alkylene carbonate to obtain an intermediate carbamate deriviative which is subsequently treated with diketene.
  • a substituted aminobenzonitrile such as methyl substituted aminobenzonitrile is reacted with 2-aminoethanol in the presence of a zinc acetate catalyst as set forth in Example 1 to provide an amino and methyl substituted phenyloxazoline.
  • the resulting substituted phenylaxazoline is reacted with diketene in the manner of Example 4 to produce the desired substituted aryl oxazoline.
  • the substituents on the phenyl group can be alkyl and other functionalties can include nitro and hydroxyl.
  • alkyl as used herein means an alkyl group having 1-5 carbon atoms.
  • Example 1 procedure was followed starting with 3-aminobenzonitrile in place of the 4-amino compound, providing white, crystalline APOXO isomer in a 75% yield, with mp 126-128° C.
  • FT-IR and 1 H NMR confirmed the structure shown below:
  • Example 1 was followed, with replacement of the 2-aminoethanol by 3-aminopropanol (3-hydroxypropyl amine) for the oxazine synthesis procedure.
  • This Example illustrates an alternative synthesis of the above compound.
  • 4-APOXO was reacted with t-butyl acetoacetate to yield 4-AAOXO in excess of 85% accordinging to the following reaction conditions: 30 g of 4-APOXO were charged to a 500 ml round bottom flask equipped with a mechanical stirrer, thermometer, Dean-Stark trap and reflux condenser. 200 ml of xylene was added followed by 29.3 g of t-butyl acetoacetate. The reaction mixture was heated with stirring to 105° C. The rapid evolution of t-butanol began at this point and continued for 15-20 minutes. The solvent was removed under reduced pressure and the solid residue of the desired product was recrystallized twice from acetonitrile and had a m.p. 170-171° C.
  • Example 4 This is a duplication of Example 4, except using different starting material.
  • a 250 ml three-neck, round bottom flask was fitted with a nitrogen gas inlet tube, magnetic stirrer, thermometer, and condenser.
  • 4-APOXO, 8.0 g (54 mmol) was mixed with 2,2,6-trimethyl-1,3-dioxin-4-one (TDO), 8.0 ml (61 mmol), and 120 ml of xylene.
  • TDO 2,2,6-trimethyl-1,3-dioxin-4-one
  • TDO 2,2,6-trimethyl-1,3-dioxin-4-one
  • xylene 120 ml
  • Example 4 Using Example 4 procedure, 4-APOXI was treated with a slight excess of diketene to produce crude 4-AAOXI in essentially quantitative yield. Recrystallization from acetonitrile gave the new monomer in 88% yield, having mp 133-134° C. The structure, shown below, was confirmed by elemental analysis, FT-IR and 1 H NMR spectroscopy.
  • This compound was prepared by treating 4-aminobenzonitrile with a slight excess, on a molar equivalents basis, of methyl iodide in tetrahydrofuran solvent for 4 hrs at room temperature. Removal of the THF and other volatiles, followed by recrystallization, gave a 76% yield of 4-(N-methyl)aminobenzonitrile, mp 85-87° C. Using Example 1 procedure, the aforesaid substituted nitrile was treated with ethanolamine to obtain a 70% yield of 2-[4-(N-methyl) aminophenyl]oxazoline, mp 145-147° C.
  • Example 6 Following the Example 6 procedure, the aforesaid compound was treated with TDO to form the oxazoline shown below, having a methyl group attached to the nitrogen in the acetoacetanilide segment.
  • the product was recrystallized from ethyl acetate, mp 102-105° C. Elemental analysis, FT-IR, exhibiting 1726 (C—O) and 1635 (—C ⁇ N—) cm ⁇ 1 absorptions, and with 1 H NMR confirmed the below drawn structure.
  • This compound has the following structure:
  • Example 6 Using the Example 6 procedure, the aforesaid intermediate was treated with a slight molar excess of TDO in xylene solvent, obtaining the desired N-methyl-N-[2-(2-oxazolin-2-yl)ethyl] acetoacetamide as a yellow colored liquid.
  • the FT-IR, with peaks centered at 3304, 2941, 1718, and 1649 cm ⁇ 1 , and 1 H NMR spectra supported the following structure.
  • Example 18 Using Example 18 procedure, the copolymer of 3-AAOXO and 2-phenyloxazoline was obtained in high yield. FT-IR confirmed that the copolymer contained both monomer residues.
  • the desired molecular weights for the copolymers of Examples 19 and 20 are in the range of 6,000-25,000.
  • Example 18 Using Example 18 procedure, the copolymer of 4-AAOXI and 2-phenyloxazoline was obtained in high yield. FT-IR and 1 H NMR confirmed that the copolymer contained both monomer residues.
  • Example 19 illustrates the copolymerization of 4-AAOXO with ethyl oxazoline, it is obvious that the corresponding oxazine compounds could be employed.
  • Aqueous formulations of the compounds of this invention can be produced by copolymerizing the compounds with ethyl oxazoline. Specifically the ethyl oxazoline should be present in an amount of 90 mole percent. When 4-AAOXO was employed, these solutions can be mixed with a crosslinker and drawn down over any substrate.
  • the monomers of this invention when further crosslinked at room temperature result in polymers useful in coatings, inks, overprint varnishes, and surface treatment applications.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

A novel compound having the formula:
Figure US20010018516A1-20010830-C00001
wherein R is an alkyl group containing 1-5 carbon atoms or an aryl, substituted aryl, substituted or unsubstituted heteroaryl, alkyl-aryl, alkylether-aryl or O; R1 and R2 are hydrogen or a methyl group; X is O, NH, NR′ wherein R′ is an alkyl group containing 1-5 carbon atoms, or O—R″ or NR″ wherein O—R″ is O-alkyl-O or O-alkyl, NR″ is O-alkyl-ONH,
Figure US20010018516A1-20010830-C00002
wherein each instance alkyl contains 1-5 carbon atoms and n is 0 or 1.
The compound of this invention is useful as a monomer which can be polymerized and/or copolymerized by catonic polymerization.
Polymers and copolymers produced in this invention can be crosslinked and are useful in coatings, inks, overprint varnishes, and surface treatment applications.

Description

    CROSS-REFERENCE TO RELATED APPLICATIONS
  • NONE [0001]
    • STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
  • NONE [0002]
    • BACKGROUND OF THE INVENTION
  • 1. Technical Field [0003]
  • This invention relates to an aqueous coating composition such as coatings, inks, coverprint varnish and surface treatment applications containing an oxazoline or oxazine acetoacetate polymer. [0004]
  • 2. Background Art [0005]
  • In the following description of the prior art and in the Examples, the parenthetical numbers are described in the following Reference section. Acetoacetamide, acetoacetanilide, and acetoacetate functionalized chemicals are readily available, via reaction of amines or hydroxyl substituted molecules with diketene (1-3), alkyl acetoacetates, or the readily used acetoacetalation compound 2,2,6-trimethyl-1,3-dioxin-4-one, which is prepared from reaction of diketene with acetone (2,4). Organic compounds or polymers with the acetoacetamide, acetoacetanilide, or acetoacetate type functionality are known to react with a variety of other functional chemicals (1-5), including such things as amines, aldehydes, and isocyanates, giving various adducts in excellent yields at low reaction temperatures (2). Also, the acetoacetamide, acetoacetanilide, or acetoacetate group, with amine catalysts, will combine readily with the acrylate functionality, via what is commonly called the Michael addition reaction (2,5,6). Further, these acetoacetanilide, acetoacetamide, or acetoacetate groups are known to readily react with various metal compounds, such as CaO, Ca(OH)[0006] 2, BaO, CoCl2, NiCI2, etc. to form metal complexes (1,3), where the chemistry has been used to prepare polymeric catalysts (2,7,8) and crosslinked coatings (6,9-1 1). These chemicals with the acetoacetamide, acetoacetanilide, and/or acetoacetate functionality, which have three active centers, have found extensive utility in the formation of metal-complexes, manufacture of dyes and synthesis of heterocycles (1-3).
  • It is well known that cyclic imino ethers, such as oxazolines and oxazines will undergo cationic, ring-opening polymerizations (12) and zwitterionic copolymerization with such things as acrylic acid, maleimides, anhydrides, lactones, etc. (13-17). It is also well known that molecules with the oxazoline or oxazine residues will undergo ring-opening reactions with compounds such as carboxylic acids, thiols (HS-groups), phenols, alkyl halides, etc., giving 1-to-1 adducts (18-24), allowing for step-growth copolymerizations to be readily achieved with difunctional monomers. Further, it has been shown that alkyl halides will initiate ring-opening polymerization of cyclic imino ethers, as well as give 1:1 adducts (18, 25). Thus oxazolines and oxazines are excellent intermediates for synthesis of variety of polymeric materials, both thermoplastics and thermosets, by chain-growth and step-growth polymerization mechanisms or combinations thereof. In addition, the synthesis and polymerization of oxazoline and oxazine methacrylate aqueous coating compositions are also known (27). [0007]
    • REFERENCES
  • 1. U.S. Pat. No. 3,304,328 (Feb. 14, 1967) to FMC Corporation. [0008]
  • 2. N. Moszner, U. Salz, V. Rheinberger, MACROAKRON '94, 35th IUPAC Int. Symp. on Macromolecules, Jul. 11-15, 1994 paper. [0009]
  • 3. S. M. Hussain, A. M. El-Reedy, S. A. El-Sherabasy, J. Heterocyclic Chem., 25, 9-22 (1988). [0010]
  • 4. Wacker Chemicals (USA), Inc. literature, p. 16. [0011]
  • 5. R. J. Clemens, J. S. Witzman, F. Del Rector, Communications of Eastman Chemical Products, Inc. [0012]
  • 6. K. J. Edgar, K. M. Arnold, W. W. Blount, J. E. Lawniczak, and D. W. Lowman, Macromolecules 1995, 28, 4122-4128. [0013]
  • 7. T. Sato, A. Morita, I. Kamiya, T. Ota, Makromol. Chem., Rapid Comm. 11 (1990) 553. [0014]
  • 8. R. Ran, D. Fu, J. Macromol. Sci.-Chem. A27 (1990) 625. [0015]
  • 9. D. L. Trumbo, Polymer Bull. 26 (1991) 265,481. [0016]
  • 10. J. R. Grawe, B. G. Bufkin, J. Coatings Technol. 52 (1980) 73. [0017]
  • 11. U.S. Pat. No. 4,247,671 (Jan. 27, 1981) to Rohm and Haas Co. [0018]
  • 12. S. Kobayashi and T. Saegusa, Encyclopedia of Polymer Science and Engineering, Wiley & Sons, New York, Vol. 4, pp. 525-537, 1986. [0019]
  • 13. G. Odian, M. P. O'Callaghan, C. K. Chien, P. Gunatillake, M. Periyasay and D. L. Schmidt, Macromolecules, 23(4), 918-927 (1990). [0020]
  • 14. C. I. Simionescu, et.al., Polymer. Bull. (Berlin), 14(1), 79-83 (1985). [0021]
  • 15. T. Saegusa, Makromol. Chem., Suppl., 4, 73-84 (1981). [0022]
  • 16. B. L. Rivas and G. D. Pizarro, Eur. Polym. J., 25(10), 1001-1005 (1989). [0023]
  • 17. G. S. Canessa, A. S. Pooley, M. Parra and B. L. Rivas, Polym. Bull. (Berlin), [0024]
  • 11(5), 465-70 (1984). [0025]
  • 18. J. A. Frump, Chem. Rev., 71(5), 483-505 (1971). [0026]
  • 19. U.S. Pat. No. 3,758,62, (Sep. 11, 1973), to Dow Chemical. [0027]
  • 20. U.S. Pat. No. 4,600,766 (Jul. 15, 1986) to Takeda Chemical Co. [0028]
  • 21. T. Nishikubo, T. Iizawa and A. Tokairin, Mackromol. Chem., 185, 1307-1316 (1984). [0029]
  • 22. T. Kagiya, S. Narisawa, T. Maeda and K. Fukui, Polymer Letters, 4, 257-260 (1966). [0030]
  • 23. U.S. Pat. No. 4,430,491 (Feb. 7, 1984) to Ashland Chemical Co. [0031]
  • 24. B. M. Culbertson, M. L. Deviney, O. Tiba and D. D. Carlos, 33rd SAMPE Symp., Mar. 7-10, pp. 1530-1545 (1988), Ibid. [0032] 34th SAMPE Symp. May 8-11, 1989. PP.2483-2497.
  • 25. S. Kobayashi, H. Uyama, Y. Narita and J. Ishiyama, Macromolecules, 25(12), 3232-3236 (1992). [0033]
  • 26.H. Witte and W. Seelinger, Liebigs Arn. Chem., 996-1009 (1974). [0034]
  • 27.H. A. A. Rasoul, D. B. Obuchowski, D. L. Trumbo, B. M. Culbertson, and Y. Xue, Oxazoline Hydrolysis, Synthesis and Polymerization of a New Oxazoline Methacrylate, PP. 871-872 (1997). [0035]
  • The prior art fails to disclose chemical compositions, monomeric or polymeric having both the cyclic imino ether and the acetoacetamide, acetoacetenilide or acetoacetate residues on the same molecule. [0036]
    • SUMMARY OF THE INVENTION
  • The novel compound of this invention has the following formula: [0037]
    Figure US20010018516A1-20010830-C00003
  • wherein R is an alkyl group containing 1-5 carbon atoms or an aryl, substituted aryl, substituted or unsubstituted heteroaryl, alkyl-aryl, alkylether-aryl or O; R. and R[0038] 2 are hydrogen or a methyl group; X is O, NH, NR′ wherein R′ is an alkyl group containing 1-5 carbon atoms, or O—R″ or NR″ wherein O—R″ is O-alkyl-O or O-alkyl, NR″ is O-alkyl-ONH, or
    Figure US20010018516A1-20010830-C00004
  • wherein each instance alkyl contains 1-5 carbon atoms and n is 0 or 1. [0039]
  • The compounds of this invention are monomers which may be polymerized or copolymerized, via cationic, ring-opening polymerization of the cyclic imino ether residues, producing polymers with pendant acetoacetamide, acetoacetanilide and/or acetoacetate groups. Polymers of the aforesaid type may be readily crosslinked, via a variety of reactions as explained in the background art, to produce crosslinked materials useful in coatings, adhesives, and other applications. Further, these monomers and polymers are shown to readily form metal complexes with a variety of metal salts, giving in many cases, highly colored monomer-metal or macromolecular-metal complexes. [0040]
  • Referring to the previous formula, in the instance where R is aryl, X is NH, R[0041] 1 and R2 are H and n is 0, this compound can be readily prepared by reacting an aminophenyl oxazoline with diketene. In the instance where R is aryl, X is NH, R. and R2 are H and n is 1,2-(4-aminophenyl) oxazine was reacted with diketene. The compound where R is aryl, X is NR′, R1 and R2 are H and n is 0, this compound is prepared by reacting aminobenzonitrile with an alkyl iodide to obtain an alkylaminobenzonitrile which is treated with ethanolamine to obtain alkylaminophenyl oxazoline. The resulting oxazoline compound is subsequently treated with 2, 2, 6-trimethyl-1,3-dioxin-4-one (TDO). The compound where R is aryl, X is NH, R, R1 and R2 are CH3 and n is 0 is prepared by reacting ethylaminobenzoate with methylaminopropanol to yield a dimethyl derivative of aminophenyl oxazoline with the resulting oxazaline treated with TDO. The compound where R is alkyl, X is alkyl, R1 and R2 are hydrogen and n is 0 is prepared by reacting an alkylamino alkylnitrile with ethanolamine to obtain alkylamino alkyloxazoline which is subsequently treated with TDO. As to the compound where R, R1, R2 and n are as immediately and previously described but X is O-alkyl, it is obtained by reacting hydroxyalkyl oxazoline and TDO. In those instances where R is aryl, R1 and R2 are hydrogen, n is 0 and X is O-alkyl-O, O-alkyl-CNH or
    Figure US20010018516A1-20010830-C00005
  • the following procedures were employed. Where X is O-alkyl-O, hydroxy-alkylphenyl oxazoline was reacted with TDO; where X is O-alkyl-CONH aminophenyl oxazoline was reacted with an alkyllactone resulting in a hydroxyalkyl substituted amide of the oxazoline compound which is subsequently treated with TDO; where X is [0042]
    Figure US20010018516A1-20010830-C00006
  • aminophenyl oxazoline was treated with an alkylene carbonate to obtain an intermediate carbamate deriviative which is subsequently treated with diketene. [0043]
  • To synthesize substituted aryl oxazolines, a substituted aminobenzonitrile such as methyl substituted aminobenzonitrile is reacted with 2-aminoethanol in the presence of a zinc acetate catalyst as set forth in Example 1 to provide an amino and methyl substituted phenyloxazoline. The resulting substituted phenylaxazoline is reacted with diketene in the manner of Example 4 to produce the desired substituted aryl oxazoline. As indicated, the substituents on the phenyl group can be alkyl and other functionalties can include nitro and hydroxyl. [0044]
  • To prepare the compounds of general formula where R is heteroaryl, a heterogroup of the formula: [0045]
    Figure US20010018516A1-20010830-C00007
  • is reacted with 2-aminoethanol as previously described to result in a compound of the formula: [0046]
    Figure US20010018516A1-20010830-C00008
  • which is subsequently reacted with diketene. In the foregoing formula X=sulfur, oxygen, or NH or NR where R is alkyl and Y=hydrogen, bromine, chlorine, iodine fluorine, amino or hydroxyl. [0047]
  • To prepare compounds of the general formula where R is alkyl-aryl, a compound of the formula: [0048]
    Figure US20010018516A1-20010830-C00009
  • is reacted with 2-aminoethanol as previously described to result in: [0049]
    Figure US20010018516A1-20010830-C00010
  • which is subsequently heated with diketene to produce the desired alky-aryl substituted or unsubstituted acetoacetoxazoaline. In this instance X=hydrogen, carboxyl, halogen, alkyl or aryl. [0050]
  • To synthesize compounds of the general formula where R is alkylether-aryl, a hydroxybenzonitrile is reacted with 2-aminoethanol as previously described to result in a hydroxy substituted phenyloxazoline. This intermediate oxazoline is reacted with, for example ethylene oxide, to produce a compound of the formula: [0051]
    Figure US20010018516A1-20010830-C00011
  • which is further reacted with diketene to produce the desired alkylether-aryl substituted acetoacetate oxazoline. [0052]
  • The term “alkyl” as used herein means an alkyl group having 1-5 carbon atoms. [0053]
  • The Examples which follow are intended as an illustration of certain preferred embodiments of the invention, and no limitation of the invention is implied. [0054]
    • EXAMPLE 1 2-(4-Aminophenyl)oxazoline (4-APOXO)
  • Using known procedures for the synthesis of cyclic imino ethers from nitriles (18,26), 4-aminobenzonitrile was treated with an excess of 2-aminoethanol (1 part nitrile/2 parts aminoalcohol) in refluxing xylene, with 3.5 wt. % zinc acetate catalyst, with all under a slow nitrogen stream. The solution was heated until no NH[0055] 3 was detected in the off gas. After removal of the xylene, the crude solid product was obtained in high yield. The crude product was recrystallized from acetonitrile to obtain an 82% yield of white, crystalline 4-APOXO having mp 163-165° C., reported 158-160° C. The structure of the monomer was confirmed by FT-IR and 1H NMR. Structure of 4-APOXO is as follows:
    Figure US20010018516A1-20010830-C00012
    • EXAMPLE 2 2-(3-aminophenyl) oxazoline (3-APOXO)
  • Example 1 procedure was followed starting with 3-aminobenzonitrile in place of the 4-amino compound, providing white, crystalline APOXO isomer in a 75% yield, with mp 126-128° C. FT-IR and [0056] 1H NMR confirmed the structure shown below:
    Figure US20010018516A1-20010830-C00013
    • EXAMPLE 3 2-(4-aminophenyl) oxazine (4-APOXI)
  • While this monomer is new to the literature, it is obvious the monomer may be made by published techniques used for Example 1 and 2 compositions. Example 1 procedure was followed, with replacement of the 2-aminoethanol by 3-aminopropanol (3-hydroxypropyl amine) for the oxazine synthesis procedure. The heretofore unreported crystalline 4-APOXI, with mp 177-178° C., was obtained in 92% yield. The structure, shown below, was confirmed by elemental analysis, FT-IR and [0057] 1H NMR.
    Figure US20010018516A1-20010830-C00014
    • EXAMPLE 4 2-(4-acetoacetanilide)oxazoline (4-AAOXO)
  • To a stirred solution of 4-APOXO, 20.4 g (0.136 mol), in 280 ml of tetrahydrofuran (THF), contained in a 500 ml round bottom flask fitted with a reflux condenser and N[0058] 2 sparge tube, was added 10.8 ml (0.14 mol) of diketene in dropwise fashion, keeping the temperature at 0-5° C. After 30 min, the temperature was allowed to rise to room temperature and the flask and contents allowed to sit for several hours. Evaporation of the solvent produced the crude, solid product in essentially quantitative yield. Recrystallization from acetonitrile produced white, crystalline 4-AAOXO with mp 171-172° C. Elemental analysis, FT-IR and 1H NMR confirmed the structure of the heretofore unreported monomer, as shown below:
    Figure US20010018516A1-20010830-C00015
    • EXAMPLE 5 2-(4-acetoacetanilide) oxazoline (4-AAOXO)
  • This Example illustrates an alternative synthesis of the above compound. 4-APOXO was reacted with t-butyl acetoacetate to yield 4-AAOXO in excess of 85% acording to the following reaction conditions: 30 g of 4-APOXO were charged to a 500 ml round bottom flask equipped with a mechanical stirrer, thermometer, Dean-Stark trap and reflux condenser. 200 ml of xylene was added followed by 29.3 g of t-butyl acetoacetate. The reaction mixture was heated with stirring to 105° C. The rapid evolution of t-butanol began at this point and continued for 15-20 minutes. The solvent was removed under reduced pressure and the solid residue of the desired product was recrystallized twice from acetonitrile and had a m.p. 170-171° C. [0059]
    • EXAMPLE 6 2-(4-acetoacetanilide) oxazoline (4-AAOXO)
  • This is a duplication of Example 4, except using different starting material. A 250 ml three-neck, round bottom flask was fitted with a nitrogen gas inlet tube, magnetic stirrer, thermometer, and condenser. 4-APOXO, 8.0 g (54 mmol), was mixed with 2,2,6-trimethyl-1,3-dioxin-4-one (TDO), 8.0 ml (61 mmol), and 120 ml of xylene. The solution was heated at reflux, under a slow nitrogen stream, for 4 hrs. On cooling, the crude 4-AAOXO precipated from solution. The 4-AAOXO was collected, washed with diethyl ether, and dried in a vacuum to obtain the slightly yellow, crystalline monomer in 83% yield, having mp 169-171° C. FT-IR and [0060] 1H NMR confirmed the product to be the same as that prepared in Example 4.
    • EXAMPLE 7 2-(3-acetoacetanilide)oxazoline (3-AAOXO)
  • Using Example 4 procedure, 3-APOXO was treated with a slight excess of diketene to produce 3-AAOXO in 65% yield, with the recrystallized waxy solid having mp 77-78° C. Elemental, FT-IR and [0061] 1H NMR confirmed the 3-AAOXO structure, as shown below:
    Figure US20010018516A1-20010830-C00016
    • EXAMPLE 8 2-(4-acetoacetanilide)oxazine (4-AAOXI)
  • Using Example 4 procedure, 4-APOXI was treated with a slight excess of diketene to produce crude 4-AAOXI in essentially quantitative yield. Recrystallization from acetonitrile gave the new monomer in 88% yield, having mp 133-134° C. The structure, shown below, was confirmed by elemental analysis, FT-IR and [0062] 1H NMR spectroscopy.
    Figure US20010018516A1-20010830-C00017
    • EXAMPLE 9 N-Methyl-N-[4-(2-oxazolin-2-yl) phenyl]acetoacetamide
  • This compound was prepared by treating 4-aminobenzonitrile with a slight excess, on a molar equivalents basis, of methyl iodide in tetrahydrofuran solvent for 4 hrs at room temperature. Removal of the THF and other volatiles, followed by recrystallization, gave a 76% yield of 4-(N-methyl)aminobenzonitrile, mp 85-87° C. Using Example 1 procedure, the aforesaid substituted nitrile was treated with ethanolamine to obtain a 70% yield of 2-[4-(N-methyl) aminophenyl]oxazoline, mp 145-147° C. Following the Example 6 procedure, the aforesaid compound was treated with TDO to form the oxazoline shown below, having a methyl group attached to the nitrogen in the acetoacetanilide segment. The product was recrystallized from ethyl acetate, mp 102-105° C. Elemental analysis, FT-IR, exhibiting 1726 (C—O) and 1635 (—C═N—) cm[0063] −1 absorptions, and with 1H NMR confirmed the below drawn structure.
  • This compound has the following structure: [0064]
    Figure US20010018516A1-20010830-C00018
    • EXAMPLE 10 N-[4-(4,4-dimethyl-2-oxazolin-2-yl)phenyl]acetoacetamide
  • Ethyl p-aminobenzoate, 20.65 g (0.125 mol), 2-methyl-2-aminopropanol, 22.3 g (0.25 mol) 150 ml of xylene, and 0.25 g of lithium amide were combined and heated at the reflux temperature for 50 hr. The alcohol and water liberated was collected in a Dean-Stark trap, providing indication when the reaction was complete. The xylene solvent was removed and the viscous liquid was added to water to precipitate the product. After drying, a 15.5 g (65%) yield of the 4,4-dimethyl derivative of 4-aminophenyl oxazoline was obtained. The product was recrystallized from ethyl acetate, giving white, crystalline material with mp 172° C. FT-IR, with peaks centered at 3445 (NH), 1635 (—C═N—), and 1602 (phenyl) cm[0065] −1 confirmed the desired amino functionalized oxazoline. Following the Example 6 procedure, TDO was used to covert the aforesaid compound to the desired acetoacetamide. The structure of this new composition is as follows:
    Figure US20010018516A1-20010830-C00019
    • EXAMPLE 11 N-Methyl-N-[2-(2-oxazolin-2-yl)ethyl]acetoacetamide
  • 3-Methylaminopropionitrile, 50 g (0.59 mol), ethanolamine, 73.2 g (1.2 mol), 3.2 g of zinc acetate, and 100 ml xylene were combined and heated at reflux under nitrogen. When no more NH[0066] 3 was detected coming from the reaction, the xylene was removed and the crude product purified by distillation, bp 80-82° C./45 mm Hg. The FT-IR, of the slightly yellow colored liquid, showed a broad NE peak at 3370 cm−1 and the expected —C═N-peak at 1637 cm−1, supporting preparation of the desired intermediate 2-[2-(N-methyl-amino) ethyl] oxazoline. Using the Example 6 procedure, the aforesaid intermediate was treated with a slight molar excess of TDO in xylene solvent, obtaining the desired N-methyl-N-[2-(2-oxazolin-2-yl)ethyl] acetoacetamide as a yellow colored liquid. The FT-IR, with peaks centered at 3304, 2941, 1718, and 1649 cm−1, and 1H NMR spectra supported the following structure.
    Figure US20010018516A1-20010830-C00020
    • EXAMPLE 12 Acetylacetonate Derivative of 2-(3-Hydroxypropyl)oxazoline
  • The compound 3-hydroxypropyl-2-oxazoline was prepared by techniques known in the patent (1 1) literature. A reaction flask was charged with 10.6 g (0.5mol) of 3-hydroxypropyl-2-oxazoline, 11.4 g (0.08 mol) of TDO, and 100 ml of xylene. Heating with stirring under nitrogen at the reflux temperature of xylene for 6 hr. followed by removal of volatiles, gave a viscous oil. The FT-IR and [0067] 1H NMR spectra were supportive of the following structure.
    Figure US20010018516A1-20010830-C00021
    • EXAMPLE 13 Acetylacetonate Derivative of 2-(3-Hydroxypentyl)oxazoline
  • Using the technique outlined in Example 12, 2-(5-hydroxypentyl) oxazoline was prepared and treated with excess TDO to obtain a good yield of the desired acetylacetonate derivative shown below. The FT-IR and [0068] 1H NMR confirmed the following structure.
    Figure US20010018516A1-20010830-C00022
    • EXAMPLE 14 Acetylacetonate Derivative of 2-(p-Hydroxyethoxyphenyloxazoline)
  • A 250 ml. round bottom, three-neck flask was charged with 2-(p-hydroxyethoxyphenyl) oxazoline, 8.28 g (0.04 mol TDO, 11.36 g (0.08 mol) and 120 ml of xylene. The solution was stirred and heated at reflux, under nitrogen, for 5 hr. Evaporation of the solvent gave a high yield of the crude, solid product. After washing with ethyl acetate, the product was recrystalized from petroleum ether to give a good yield of the desired compound, mp 72-75° C. Elemental analysis, FT-IR and [0069] 1H NMR spectra supported the structure shown below.
    Figure US20010018516A1-20010830-C00023
    • EXAMPLE 15 Acetylacetate Derivative of the Butyrolactamide
  • The monomer 2-(4-aminophenyl)oxazoline was combined and heated under nitrogen with a slight excess of butyrolactone, giving an excellent yield of the desired hydroxyalkyl substituted amide of the starting aminophenyl oxazoline compound. The latter composition was treated with an excess of TDO to obtain the compound with the following structure in excellent yield, with structure confirmed by FT-IR and [0070] 1H NMR spectroscopy.
    Figure US20010018516A1-20010830-C00024
    • EXAMPLE 16 Acetoacetate Derivative of the Hydroxyethyl carbamate prepared from 2-(4-Aminophenyl) oxazoline
  • 4-APOXO was treated with a slight molar excess of ethylene carbonate to prepare the following carbamate, as shown: [0071]
    Figure US20010018516A1-20010830-C00025
  • The above compound, which is unknown to the literature, was treated with a slight excess of diketene, per Example 4, to prepare in excellent yield the desired acetoacetate monomer, with structure shown below confirmed by FT-IR and [0072] 1H NMR spectroscopy.
    Figure US20010018516A1-20010830-C00026
    • EXAMPLE 17 Polymerization of 2-(4-acetoacetanilide)oxazoline (4-AAOXO)
  • The monomer 4-AAOXO, 4.0g, and anisole (50 ml) solvent, along with a catalytic amount (0.15 g.) of the cationic polymerization initiator, methyl tosylate (TsOCH[0073] 3), were combined under nitrogen and sealed in a small reaction flask containing a magnetic stir bar. With stirring, the polymerization was run for 10 hr at 135° C. After cooling, the anisole solution was combined with hexane to precipitate the polymer. After collection and drying under vacuum at 45° C., the poly (4-AAOXO), soluble with difficulty in N, N-dimethylformamide (DMF), was obtained in essentially quantitative yield. The polymer structure was confirmed by FT-IR and 1H NMR analysis. Polymerization under the same procedure with acetonitrile solvent and SnCl4 initiator produced poly (4-AAOXO) which was readily soluble in DMF.
    • EXAMPLE 18 Copolymerization of 2-(4-acetoacetanilide) oxazoline (4-AAOXO) with 2-phenyloxazoline
  • The monomer 2-(4-acetoacetanilide) oxazoline [4-AAOXO], 2.5 g. and 2-phenyloxazoline (2.5g.), with 0.15 g of TsOCH[0074] 3 were mixed in a small glass vial containing 45 ml of anisole. The vial was flushed with nitrogen, sealed, and placed in a thermostatted bath at 120° C. for 13 hr. The polymer solution, after cooling, was combined with vigorously stirred petroleum ether to precipitate the copolymer. The copolymer was collected, washed with petroleum ether, and dried under vacuum at 45° C. FT-IR and 1H NMR spectra confirmed the copolymer contained both monomer residues.
    • EXAMPLE 19 Copolymerization of 4-AAOXO with ethyl oxazoline
  • Using the procedure described in Example 18, a copolymer of 4-AAOXO and 2-ethyloxazoline was produced and isolated in high yield. FT-IR and [0075] 1H NMR confirmed that the copolymer contained both monomer residues.
    • EXAMPLE 20 Copolymerization of 3-AAOXO with 2-phenyloxazoline
  • Using Example 18 procedure, the copolymer of 3-AAOXO and 2-phenyloxazoline was obtained in high yield. FT-IR confirmed that the copolymer contained both monomer residues. [0076]
  • The desired molecular weights for the copolymers of Examples 19 and 20 are in the range of 6,000-25,000. [0077]
    • EXAMPLE 21 Copolymerization of 4-AAOXI with 2-phenyloxazoline
  • Using Example 18 procedure, the copolymer of 4-AAOXI and 2-phenyloxazoline was obtained in high yield. FT-IR and [0078] 1H NMR confirmed that the copolymer contained both monomer residues.
  • While Example 19 illustrates the copolymerization of 4-AAOXO with ethyl oxazoline, it is obvious that the corresponding oxazine compounds could be employed. [0079]
    • EXAMPLE 22 Formulation
  • Aqueous formulations of the compounds of this invention can be produced by copolymerizing the compounds with ethyl oxazoline. Specifically the ethyl oxazoline should be present in an amount of 90 mole percent. When 4-AAOXO was employed, these solutions can be mixed with a crosslinker and drawn down over any substrate. [0080]
    • INDUSTRIAL APPLICABILITY
  • The monomers of this invention when further crosslinked at room temperature result in polymers useful in coatings, inks, overprint varnishes, and surface treatment applications. [0081]

Claims (60)

That which is claimed is:
1. A compound having the formula:
Figure US20010018516A1-20010830-C00027
wherein R is an alkyl group containing 1-5 carbon atoms or an aryl, substituted aryl, substituted or unsubstituted heteroaryl, alkyl-aryl, alkylether-aryl or O; R1 and R2 are hydrogen or a methyl group; X is O, NH, NR′ wherein R′ is an alkyl group containing 1-5 carbon atoms, or O—R″ or NR″ wherein O—R″ is O-alkyl-O or O-alkyl, NR″ is O-alkyl-ONH, or
Figure US20010018516A1-20010830-C00028
wherein each instance alkyl contains 1-5 carbon atoms and n is 0 or 1.
2. The compound of
claim 1
 wherein R is aryl, X is NH, NR or NR′, R1 and R2 are hydrogen or a methyl group and n is 0 or 1.
3. The compound of
claim 1
 wherein R is aryl, X is NH, R1 and R2 are hydrogen and n is 0.
4. The compound of
claim 1
 wherein R is aryl, X is NH, R1 and R2 are hydrogen and n is 1.
5. The compound of
claim 1
 wherein R is aryl, X is NR′, R1 and R2 are hydrogen and n is 0.
6. The compound of
claim 5
 wherein R′ is methyl.
7. The compound of
claim 1
 wherein R is aryl, X is NH, R1 and R2 are CH3 and n is 0.
8. The compound of
claim 1
 wherein R is an alkyl group, X is NR′, R1 and R2 are hydrogen and n is 0.
9. The compound of
claim 8
 wherein R is ethyl.
10. The compound of
claim 8
 wherein R′ is methyl.
11. The compound of
claim 1
 wherein R is an alkyl group, X is O alkyl, R1 and R2 are hydrogen and n is 0.
12. The compound of
claim 11
 wherein O-alkyl is O-propyl.
13. The compound of
claim 11
 wherein O-alkyl is O-pentyl.
14. The compound of
claim 11
 wherein O-alkyl is O-methyl.
15. The compound of
claim 1
 wherein R is aryl, X is O-alkyl-O, R1 and R2 are hydrogen and n is 0.
16. The compound of
claim 15
 wherein O-alkyl-O is O-ethyl-O.
17. The compound of
claim 1
 wherein R is aryl, X is O-alkyl-ONH, R1 and R2 are hydrogen and n is 0.
18. The compound of
claim 17
 wherein O-alkyl-ONH is butyrolactamide.
19. The compound of
claim 1
 wherein R is aryl, X is
Figure US20010018516A1-20010830-C00029
R1 and R2 are hydrogen and n is 0.
20. The compound of
claim 19
 wherein
Figure US20010018516A1-20010830-C00030
21. A polymer or copolymer comprising an oxazoline or oxazine ring opening
Figure US20010018516A1-20010830-C00031
wherein R is an alkyl group containing 1-5 carbon atoms or an aryl, substituted aryl, substituted or unsubstituted heteroaryl, alkyl-aryl, alkylether-aryl or O; R1 and R2 are hydrogen or a methyl group; X is O, NH, NR′ wherein R′ is an alkyl group containing 1-5 carbon atoms, or O—R″ or NR″ wherein O—R″ is O-alkyl-O or O-alkyl, NR″ is O-alkyl-ONH, or
Figure US20010018516A1-20010830-C00032
wherein each instance alkyl contains 1-5 carbon atoms and n is 0 or 1.
22. The polymer or copolymer of
claim 21
 wherein R is aryl, X is NH, NR or NR′, R1 and R2 are hydrogen or a methyl group and n is 0 or 1.
23. The polymer or copolymer of
claim 21
 wherein R is aryl, X is NH, R1 and R2 are hydrogen and n is 0.
24. The polymer or copolymer of
claim 21
 wherein R is aryl, X is NH, R1 and R2 and hydrogen and n is 1.
25. The polymer or copolymer of
claim 21
 wherein R is aryl, X is R′, R1 and R2 are hydrogen and n is 0.
26. The polymer or copolymers of
claim 25
 wherein R′ is methyl.
27. The polymer or copolymer of
claim 21
 wherein R is aryl, X is NH, R1 and R2 are CH3 and n is 0.
28. The polymer or copolymer of
claim 21
 wherein R is an alkyl group, X is NR′, R1 and R2 are hydrogen and n is 0.
29. The polymer or copolymer of
claim 28
 wherein R is ethyl.
30. The polymer or copolymer of
claim 28
 wherein R′ is methyl.
31. The polymer or copolymer of
claim 21
 wherein R is an alkyl group, X is O-alkyl, R1 and R2 are hydrogen and n is 0.
32. The polymer or copolymer of
claim 31
 wherein O-alkyl is O-propyl.
33. The polymer or copolymer of
claim 31
 wherein O-alkyl is O-pentyl.
34. The polymer or copolymer according to
claim 31
 wherein O-alkyl is O methyl.
35. The polymer or copolymer of
claim 21
 wherein R is aryl, X is O-alkyl-O, R1 and R2 are hydrogen and n is 0.
36. The polymer or copolymer of
claim 35
 wherein O-alkyl-O is O-ethyl-O.
37. The polymer or copolymer of
claim 21
 wherein R is aryl, X is O-alkyl-ONH, R1 and R2 are hydrogen and n is 0.
38. The polymer or copolymer of
claim 37
 wherein O-alkyl-ONH is butyrolactamide.
39. The polymer or copolymer according to
claim 21
 wherein R is aryl, X is
Figure US20010018516A1-20010830-C00033
R1 and R2 are hydrogen and n is 0.
40. The polymer or copolymer of
claim 39
 wherein
Figure US20010018516A1-20010830-C00034
41. An aqueous formulation comprising (a) a polymeric ingredient having an oxazoline or oxazine ring opening moiety derived from a compound having the formula:
Figure US20010018516A1-20010830-C00035
wherein R is an alkyl group containing 1-5 carbon atoms or an aryl, substituted aryl, substituted or unsubstituted heteroaryl, alkyl-aryl, alkylether-aryl or O; R1 and R2 are hydrogen or a methyl group; X is O, NH, NR′ wherein R′ is an alkyl group containing 1-5 carbon atoms, or O—R″ or NR″ wherein O—R″ is O-alkyl-O or O-alkyl-, NR″ is O-alkyl-ONH, or
Figure US20010018516A1-20010830-C00036
wherein each instance alkyl contains 1-5 carbon atoms and n is 0 or 1.
42. The aqueous formulation of
claim 41
 wherein R is aryl, X is NH, NR or NR′, R1 and R2 are hydrogen or a methyl group and n is 0 or 1.
43. The aqueous formulation of
claim 41
 wherein R is aryl, X is NH, R1 and R2 are hydrogen and n is 0.
44. The aqueous formulation of
claim 41
 wherein R is aryl, X is NH, R1 and R2 are hydrogen and n is 1.
45. The aqueous formulation of
claim 41
 wherein R is aryl, X is NR′, R1 and R2 are hydrogen and n is 0.
46. The aqueous formation of
claim 45
 wherein R′ is methyl.
47. The aqueous formulation of
claim 41
 wherein R is aryl, X is NH, R1 and R2are CH3 and n is 0.
48. The aqueous formulation of
claim 41
 wherein R is an alkyl group, X is NR′, R1 and R2 are hydrogen and n is 0.
49. The aqueous formulation of
claim 48
 wherein R is ethyl.
50. The aqueous formation of
claim 48
 wherein R′ is methyl.
51. The aqueous formulation of
claim 41
 wherein R is alkyl, X is O-alkyl, R1 and R2 are hydrogen and n is 0.
52. The aqueous formulation of
claim 51
 wherein O-alkyl is O-propyl.
53. The aqueous formulation of
claim 51
 wherein O-alkyl is O-pentyl.
54. The aqueous formulation of
claim 51
 wherein O-alkyl is O-methyl.
55. The aqueous formulation of
claim 41
 wherein R is aryl, X is O-alkyl-O, R1 and R2 are hydrogen and is 0.
56. The aqueous formulation of
claim 55
 wherein O-alkyl-O is O-ethyl-O.
57. The aqueous formulation of
claim 41
 wherein R is aryl, X is O-alkyl-ONH, R1 and R2 are hydrogen and n is 0.
58. The aqueous formulation of
claim 57
 wherein O-alkyl-O NH is butyrolactamide.
59. The aqueous formulation of
claim 41
 wherein R is aryl, X is O-alkyl-
Figure US20010018516A1-20010830-C00037
R1 and R2 are hydrogen and n is 0.
60. The aqueous formulation of
claim 59
 wherein
Figure US20010018516A1-20010830-C00038
NH.
US09/819,242 1999-05-06 2001-03-28 Oxazoline or oxazine acetoacetate aqueous coating compositions Expired - Lifetime US6433116B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/819,242 US6433116B2 (en) 1999-05-06 2001-03-28 Oxazoline or oxazine acetoacetate aqueous coating compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/306,302 US6235901B1 (en) 1999-05-06 1999-05-06 Oxazoline or oxazine acetoacetate aqueous coating compositions
US09/819,242 US6433116B2 (en) 1999-05-06 2001-03-28 Oxazoline or oxazine acetoacetate aqueous coating compositions

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US09/306,302 Division US6235901B1 (en) 1999-05-06 1999-05-06 Oxazoline or oxazine acetoacetate aqueous coating compositions

Publications (2)

Publication Number Publication Date
US20010018516A1 true US20010018516A1 (en) 2001-08-30
US6433116B2 US6433116B2 (en) 2002-08-13

Family

ID=23184702

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/306,302 Expired - Lifetime US6235901B1 (en) 1999-05-06 1999-05-06 Oxazoline or oxazine acetoacetate aqueous coating compositions
US09/819,242 Expired - Lifetime US6433116B2 (en) 1999-05-06 2001-03-28 Oxazoline or oxazine acetoacetate aqueous coating compositions

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/306,302 Expired - Lifetime US6235901B1 (en) 1999-05-06 1999-05-06 Oxazoline or oxazine acetoacetate aqueous coating compositions

Country Status (3)

Country Link
US (2) US6235901B1 (en)
AU (1) AU4821800A (en)
WO (1) WO2000068212A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101799618B1 (en) 2010-12-14 2017-11-20 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Oxazolinyl-containing polymers and grafted compounds prepared from the oxazolinyl-containing polymers

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6235901B1 (en) * 1999-05-06 2001-05-22 S. C. Johnson Commercial Markets, Inc. Oxazoline or oxazine acetoacetate aqueous coating compositions
EP4081603A4 (en) * 2019-12-26 2023-08-23 Dow Global Technologies LLC Aqueous coating composition and process for preparing the same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3304328A (en) 1963-10-25 1967-02-14 Fmc Corp Preparation of acetoacetarylamides
US3563920A (en) * 1969-06-16 1971-02-16 Dow Chemical Co Bi-2-oxazoline and oxazine ethers and thioethers
US3758629A (en) 1971-05-07 1973-09-11 Dow Chemical Co By reaction with a di-2-oxazoline cross linking of addition polymers containing combined free carboxyl
US4016192A (en) * 1974-12-30 1977-04-05 The Dow Chemical Company Unsaturated acrylic acid-oxazoline reaction products
US4247671A (en) 1979-04-11 1981-01-27 Rohm And Haas Company Hydrocurable compositions containing oxazoline groups
US4430491A (en) 1982-09-30 1984-02-07 Ashland Oil, Inc. Poly(ether-amide) polymeric compositions
JPS6090219A (en) 1983-10-21 1985-05-21 Takeda Chem Ind Ltd Production of thermosetting resin
US4889765A (en) * 1987-12-22 1989-12-26 W. R. Grace & Co. Ink-receptive, water-based, coatings
NL9000762A (en) * 1990-03-31 1991-10-16 Stamicarbon BLOCK COPOLYMERS OF TETRAHYDROFURAN AND OXAZOLINE, HYDROLYSIS PRODUCTS THEREOF AND A PROCESS FOR MANUFACTURING THESE BLOCK COPOLYMERS.
US5418277A (en) * 1994-04-26 1995-05-23 E. I. Du Pont De Nemours And Company Aqueous ink jet inks containing fluorinated polymers
US6060554A (en) * 1997-01-24 2000-05-09 Kansai Paint Co., Ltd. Aqueous coating and method for film formation using the same
US6063885A (en) * 1998-03-10 2000-05-16 S. C. Johnson Commercial Markets, Inc. Oxazoline or oxazine methacrylate aqueous coating compositions
US6235901B1 (en) * 1999-05-06 2001-05-22 S. C. Johnson Commercial Markets, Inc. Oxazoline or oxazine acetoacetate aqueous coating compositions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101799618B1 (en) 2010-12-14 2017-11-20 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Oxazolinyl-containing polymers and grafted compounds prepared from the oxazolinyl-containing polymers

Also Published As

Publication number Publication date
US6235901B1 (en) 2001-05-22
US6433116B2 (en) 2002-08-13
WO2000068212A1 (en) 2000-11-16
AU4821800A (en) 2000-11-21

Similar Documents

Publication Publication Date Title
US5635571A (en) Polymerizable macromonomers and polymers prepared therefrom
Reetz et al. Metal‐free Carbanion Salts as Initiators for the Anionic Polymerization of Acrylic and Methacrylic Acid Esters
HU214688B (en) Process for solving compounds with urea derivatives and process for producing thereof
JPH04234859A (en) Azlactone michael adduct
US4785070A (en) Imidazolinone-containing copolymer
CN106947067A (en) Preparation method of polyester
US6433116B2 (en) Oxazoline or oxazine acetoacetate aqueous coating compositions
US3483145A (en) Polymers of acyloxyalkyl substituted oxazolines
US3563920A (en) Bi-2-oxazoline and oxazine ethers and thioethers
Yokoyama et al. Synthesis and polymerization of 2, 6, 7-trioxabicyclo [2.2. 2] octane and its derivatives
JP4837166B2 (en) Ester of mercapto fatty acid and polyoxyalkylene compound and method for producing the same
US6040482A (en) Oxyalkylene-substituted aminophenol intermediate
US4528320A (en) Low temperature, moisture cure coating composition
US4145524A (en) Preparation of heterocyclic block copolymer from perfluoroalkylene oxide α, ω-diamidoximes
US3749683A (en) Bi-2-oxazoline and oxazine ethers and thioethers
US4933463A (en) Polymerizable pyrrolidonyl oxazoline monomers, homopolymers and copolymers
US6063885A (en) Oxazoline or oxazine methacrylate aqueous coating compositions
US4159383A (en) N,N-Disubstituted acryl- and methacrylamides
US3833521A (en) Process for the partial deacylation of poly(n-acyl-alkylenimines)
Culbertson et al. Synthesis, characterization and polymerization of acetylacetate, acetylacetamide or acetylacetanilide substituted cyclic imino ethers, new metal chelating monomers and polymers
Overberger et al. Synthesis of optically active polynucleotide analogs with polytrimethylenimine backbones and thymine moieties
Jakisch et al. A new bifunctional coupling agent: synthesis and model reactions
WO1991004996A1 (en) Preparation of open chain poly(reissert compounds)
Jassim et al. Synthesis and Characterization of Some New Monemer and Polymers Containing Hetero Cyclic Rings With Study of Their Physical Properties.
US4038266A (en) Azo-bisanhydride of trimellitic anhydride

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

AS Assignment

Owner name: JOHNSON POLYMER, LLC, WISCONSIN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JOHNSONDIVERSEY, INC. F/K/A JOHNSON COMMERCIAL MARKETS, INC.;REEL/FRAME:014491/0382

Effective date: 20040210

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: BASF CORPORATION,NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JOHNSON POLYMER, LLC.;REEL/FRAME:018171/0942

Effective date: 20060629

Owner name: BASF CORPORATION, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:JOHNSON POLYMER, LLC.;REEL/FRAME:018171/0942

Effective date: 20060629

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12